AIM
SRTA
ARK Investment Management’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.7M | Buy |
8,599,634
+458,990
| +6% | +$1.85M | 0.25% | 59 |
|
|
2025
Q1 | $22.2M | Buy |
8,140,644
+89,545
| +1% | +$244K | 0.22% | 61 |
|
|
2024
Q4 | $34.2M | Buy |
8,051,099
+833,848
| +12% | +$3.54M | 0.29% | 53 |
|
|
2024
Q3 | $21.2M | Buy |
7,217,251
+774,114
| +12% | +$2.28M | 0.19% | 64 |
|
|
2024
Q2 | $22.4M | Buy |
6,443,137
+230,216
| +4% | +$801K | 0.2% | 65 |
|
|
2024
Q1 | $17.7M | Sell |
6,212,921
-280,864
| -4% | -$800K | 0.12% | 85 |
|
|
2023
Q4 | $22.9M | Sell |
6,493,785
-299,941
| -4% | -$1.06M | 0.14% | 74 |
|
|
2023
Q3 | $17.6M | Sell |
6,793,726
-168,511
| -2% | -$436K | 0.13% | 82 |
|
|
2023
Q2 | $27.4M | Buy |
6,962,237
+137,713
| +2% | +$543K | 0.18% | 68 |
|
|
2023
Q1 | $23.1M | Sell |
6,824,524
-196,468
| -3% | -$664K | 0.16% | 66 |
|
|
2022
Q4 | $25.1M | Sell |
7,020,992
-318,535
| -4% | -$1.14M | 0.22% | 59 |
|
|
2022
Q3 | $29.6M | Sell |
7,339,527
-514,945
| -7% | -$2.08M | 0.21% | 67 |
|
|
2022
Q2 | $54.1M | Sell |
7,854,472
-521,958
| -6% | -$3.6M | 0.32% | 50 |
|
|
2022
Q1 | $71.1M | Buy |
8,376,430
+434,873
| +5% | +$3.69M | 0.3% | 53 |
|
|
2021
Q4 | $70.1M | Buy |
7,941,557
+2,043,985
| +35% | +$18M | 0.21% | 69 |
|
|
2021
Q3 | $61.3M | Buy |
5,897,572
+1,964,340
| +50% | +$20.4M | 0.15% | 97 |
|
|
2021
Q2 | $41.3M | Buy |
+3,933,232
| New | +$41.3M | 0.08% | 138 |
|